• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应激源与类风湿关节炎:治疗药物进展引起的应激源变化。

Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents.

机构信息

Fujita Health University School of Medicine, Toyoake, Aichi, Japan.

出版信息

Rheumatol Int. 2013 Apr;33(4):887-91. doi: 10.1007/s00296-012-2457-6. Epub 2012 Jul 20.

DOI:10.1007/s00296-012-2457-6
PMID:22814792
Abstract

The significance of evaluations of stressors in rheumatoid arthritis (RA) patients was investigated from the perspective of holistic medicine. The subjects were RA patients treated in the rheumatology outpatient clinic. They included 30 patients from 1987, 30 from 2002, and 137 from 2009. To investigate the specific causes of stress, the patients were asked the question, "What do you feel is your strongest stressor?" The same patients also underwent psychological testing and was examined the disease activity. Pain was the strongest stressor in RA patients in 1987, 2002, and 2009. However, the percentage of patients citing pain as their major stressor was decreasing with each year. CRP was significantly lower in 2009 than in 2002. CRP was also significantly lower in patients who used biologics than in patients who did not. In 2009, DAS28-CRP was significantly higher in patients whose largest stressor was pain than in patients whose largest stressor was another factor. In 2009, the values for both state anxiety and trait anxiety were significantly higher in patients who said that they had stressors than in those who said they did not. The strongest stressor in RA patients was pain. However, the percentage decreased over the years with lower disease activity from advances in therapeutic agents such as biologics. Meanwhile, stressors other than pain were the same or somewhat increased, and they were related to anxiety or depression. Understanding stressors in RA is thus important in treating RA patients.

摘要

从整体医学的角度探讨了类风湿关节炎(RA)患者压力源评估的意义。研究对象为风湿免疫科门诊治疗的 RA 患者,包括 1987 年的 30 例、2002 年的 30 例和 2009 年的 137 例。为了调查压力的具体原因,向患者提出了这样的问题:“您觉得自己最大的压力源是什么?”同样的患者还接受了心理测试和疾病活动检查。1987 年、2002 年和 2009 年,疼痛都是 RA 患者的最大压力源。但是,每年提到疼痛作为主要压力源的患者比例都在减少。2009 年 CRP 明显低于 2002 年。使用生物制剂的患者 CRP 明显低于未使用生物制剂的患者。2009 年,最大压力源为疼痛的患者 DAS28-CRP 明显高于最大压力源为其他因素的患者。2009 年,报告有压力源的患者的状态焦虑和特质焦虑值均明显高于无压力源的患者。RA 患者的最大压力源是疼痛。但是,随着治疗药物(如生物制剂)的进步,疾病活动度降低,这一比例在这些年中逐渐下降。与此同时,疼痛以外的压力源保持不变或略有增加,与焦虑或抑郁有关。因此,了解 RA 患者的压力源对于治疗 RA 患者非常重要。

相似文献

1
Stressors and rheumatoid arthritis: changes in stressors with advances in therapeutic agents.应激源与类风湿关节炎:治疗药物进展引起的应激源变化。
Rheumatol Int. 2013 Apr;33(4):887-91. doi: 10.1007/s00296-012-2457-6. Epub 2012 Jul 20.
2
The longitudinal effect of biologic use on patient outcomes (disease activity, function, and disease severity) within a rheumatoid arthritis registry.在类风湿关节炎注册研究中,生物制剂使用对患者结局(疾病活动度、功能和疾病严重程度)的纵向影响。
Clin Rheumatol. 2019 Nov;38(11):3081-3092. doi: 10.1007/s10067-019-04649-4. Epub 2019 Jul 29.
3
The comparative responsiveness of the patient self-report questionnaires and composite disease indices for assessing rheumatoid arthritis activity in routine care.在常规护理中,评估类风湿关节炎活动的患者自报告问卷和综合疾病指标的比较反应性。
Clin Exp Rheumatol. 2012 Nov-Dec;30(6):912-21. Epub 2012 Dec 17.
4
Risk factors, including different biologics, associated with depression and anxiety in patients with rheumatoid arthritis: a cross-sectional observational study.类风湿关节炎患者伴发抑郁和焦虑的相关风险因素,包括不同的生物制剂:一项横断面观察性研究。
Clin Rheumatol. 2020 Mar;39(3):737-746. doi: 10.1007/s10067-019-04820-x. Epub 2019 Dec 10.
5
No predictive effect of body mass index on clinical response in patients with rheumatoid arthritis after 24 weeks of biological disease-modifying antirheumatic drugs: a single-center study.生物性改善病情抗风湿药物治疗24周后类风湿关节炎患者体重指数对临床反应无预测作用:一项单中心研究
Clin Rheumatol. 2016 May;35(5):1129-36. doi: 10.1007/s10067-016-3220-2. Epub 2016 Mar 1.
6
Inflammatory cytokine levels, disease activity, and function of patients with rheumatoid arthritis treated with combined conventional disease-modifying antirheumatic drugs or biologics.联合使用传统改善病情抗风湿药物或生物制剂治疗的类风湿关节炎患者的炎症细胞因子水平、疾病活动度及功能
Clin Rheumatol. 2016 Jul;35(7):1673-81. doi: 10.1007/s10067-016-3306-x. Epub 2016 May 17.
7
Depression is improved when low-dose tacrolimus is given to rheumatoid arthritis patients showing an inadequate response to biologic agents.对于生物制剂治疗反应不佳的类风湿关节炎患者,给予低剂量他克莫司可改善抑郁症状。
Mod Rheumatol. 2013 Sep;23(5):920-4. doi: 10.1007/s10165-012-0765-z. Epub 2012 Sep 19.
8
Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis.近期发病的类风湿关节炎患者10年间的疼痛与心理健康状况
Ann Rheum Dis. 2007 Sep;66(9):1195-201. doi: 10.1136/ard.2006.064287. Epub 2007 Mar 28.
9
Illness perceptions account for variation in positive outlook as well as psychological distress in rheumatoid arthritis.疾病认知可以解释类风湿关节炎患者积极态度和心理困扰的变化。
Psychol Health Med. 2012;17(4):427-39. doi: 10.1080/13548506.2011.626432. Epub 2011 Nov 23.
10
Associations between an expanded autoantibody profile and treatment responses to biologic therapies in patients with rheumatoid arthritis.类风湿关节炎患者中扩大的自身抗体谱与生物治疗反应之间的关联。
Int Immunopharmacol. 2021 Feb;91:107260. doi: 10.1016/j.intimp.2020.107260. Epub 2020 Dec 23.

引用本文的文献

1
Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model.失笑散改善ICR小鼠模型子宫腺肌病的发展。
Exp Ther Med. 2020 Sep;20(3):2845-2855. doi: 10.3892/etm.2020.8994. Epub 2020 Jul 13.
2
Epigallocatechin-3-gallate reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice induced with adenomyosis.表没食子儿茶素没食子酸酯可减少子宫肌层浸润、子宫过度活动和应激水平,并缓解腺肌病小鼠的全身性痛觉过敏。
Reprod Sci. 2013 Dec;20(12):1478-91. doi: 10.1177/1933719113488455. Epub 2013 May 23.

本文引用的文献

1
[Stress and rheumatoid arthritis].[压力与类风湿关节炎]
Z Rheumatol. 2010 Aug;69(6):539-43. doi: 10.1007/s00393-010-0662-9.
2
Quality-of-life assessment in rheumatoid arthritis.类风湿关节炎的生活质量评估
Pharmacoeconomics. 2008;26(10):831-46. doi: 10.2165/00019053-200826100-00004.
3
Stress as a trigger of autoimmune disease.压力作为自身免疫性疾病的触发因素。
Autoimmun Rev. 2008 Jan;7(3):209-13. doi: 10.1016/j.autrev.2007.11.007. Epub 2007 Nov 29.
4
Pain and psychological health status over a 10-year period in patients with recent onset rheumatoid arthritis.近期发病的类风湿关节炎患者10年间的疼痛与心理健康状况
Ann Rheum Dis. 2007 Sep;66(9):1195-201. doi: 10.1136/ard.2006.064287. Epub 2007 Mar 28.
5
Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial.早期类风湿关节炎患者四种不同治疗策略的临床和影像学结果(BeSt研究):一项随机对照试验
Arthritis Rheum. 2005 Nov;52(11):3381-90. doi: 10.1002/art.21405.
6
Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate.接受英夫利昔单抗和甲氨蝶呤治疗的类风湿关节炎患者在两年内身体功能、结构损伤以及体征和症状持续改善。
Arthritis Rheum. 2004 Apr;50(4):1051-65. doi: 10.1002/art.20159.
7
A SELF-RATING DEPRESSION SCALE.一份自评抑郁量表。
Arch Gen Psychiatry. 1965 Jan;12:63-70. doi: 10.1001/archpsyc.1965.01720310065008.
8
Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study.类风湿关节炎初发几年的生活质量概况:EURIDISS纵向研究结果
Arthritis Rheum. 2001 Apr;45(2):111-21. doi: 10.1002/1529-0131(200104)45:2<111::AID-ANR162>3.0.CO;2-E.
9
Perceived stressors and coping strategies among individuals with rheumatoid arthritis.类风湿关节炎患者的感知应激源与应对策略
J Adv Nurs. 1997 Jun;25(6):1144-50. doi: 10.1046/j.1365-2648.1997.19970251144.x.
10
Stress caused by rheumatoid arthritis: relation among subjective stressors of the disease, disease status, and well-being.类风湿关节炎所致压力:疾病主观应激源、疾病状态与幸福感之间的关系。
J Behav Med. 1993 Jun;16(3):309-21. doi: 10.1007/BF00844762.